Molecular Remission After Allo-SCT in a Patient With Post-Essential Thrombocythemia Myelofibrosis Carrying the MPL (W515A) Mutation

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2009.231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Recent Advances in Understanding Myelofibrosis and Essential Thrombocythemia

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Presence of Atypical Thrombopoietin Receptor (MPL) Mutations in Triple-Negative Essential Thrombocythemia Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Prinzmetal Angina in a Young Patient With Essential Thrombocythemia, After Anagrelide Initiation - Case Report and Literature Review

ARS Medica Tomitana
BiochemistryMedicineGeneticsMolecular Biology
2018English

Takotsubo Cardiomyopathy in a Patient With Essential Thrombocythemia Treated With Anagrelide: Case Report

Cor et Vasa
Cardiovascular MedicineCardiology
2018English

Successful Management of Candida Krusei Monoarthritis After Allo-SCT

Bone Marrow Transplantation
TransplantationHematology
2013English

Pericardial Hemorrhage Due to Acetylsalicylic Acid in a Patient With Essential Thrombocythemia

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2007English

Retroperitoneal Hemorrhage After Bone Marrow Aspiration and Biopsy in an Essential Thrombocythemia Patient

Korean Journal of Medicine
2015English

Essential Thrombocythemia

New England Journal of Medicine
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy